Skip to main content

Advertisement

SpringerLink
Log in

Functional investigation of a venous thromboembolism GWAS signal in a promoter region of coagulation factor XI gene

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Coagulation factor XI (FXI) is essential for normal function of the intrinsic pathway of blood coagulation. A nucleotide variant (rs3756008) in the promoter region of the FXI gene was recently reported for association with venous thromboembolism. This study aimed to examine promoter activity of the rs3756008 or other variants linked with it. Luciferase assay was analyzed with minigenes including haplotypes (AA with frequency of 0.62 and TG with frequency of 0.38) of 2 completely linked nucleotide variants (rs3756008 and rs3756009) in 5′-upstream region of the FXI gene. While their expression did not differ in hepatic cell (P > 0.05), the major haplotype (AA) made a significantly more expression (P < 0.05) than the minor haplotype (TG) in human embryonic kidney 293 cells. Further luciferase analysis with additional haplotypes (artificial; TA, AG) revealed that the large expression was caused by the major allele of rs3756008 (P < 0.05), but not by that of rs3756009 (P > 0.05). We suggested that the minor allele of rs3756008 in the promoter of FXI gene could reduce its expression in kidney.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J (2008) Harrison’s principles of internal medicine. In: Konkle BA (ed) Bleeding and thromobosis, 17th edn. McGrau-Hill, New York, pp 363–369

    Google Scholar 

  2. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 342:696–701

    Article  PubMed  CAS  Google Scholar 

  3. Tarumi T, Kravtsov DV, Zhao M, Williams SM, Gailani D (2002) Cloning and characterization of the human factor XI gene promoter: transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha) is required for hepatocyte-specific expression of factor XI. J Biol Chem 277:18510–18516

    Article  PubMed  CAS  Google Scholar 

  4. Sabater-Lleal M, Martinez-Perez A, Buil A, Folkersen L, Souto JC, Bruzelius M, Borrell M, Odeberg J, Silveira A, Eriksson P, Almasy L, Hamsten A, Soria JM (2012) A genome-wide association study identifies KNG1 as a genetic determinant of plasma factor XI level and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 32:2008–2016

    Article  PubMed  CAS  Google Scholar 

  5. Zhang H, Lowenberg EC, Crosby JR, MacLeod AR, Zhao C, Gao D, Black C, Revenko AS, Meijers JC, Stroes ES, Levi M, Monia BP (2010) Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Blood 116:4684–4692

    Article  PubMed  CAS  Google Scholar 

  6. Austin H, De Staercke C, Lally C, Bezemer ID, Rosendaal FR, Hooper WC (2011) New gene variants associated with venous thrombosis: a replication study in White and Black Americans. J Thromb Haemost 9:489–495

    Article  PubMed  CAS  Google Scholar 

  7. Germain M, Saut N, Greliche N, Dina C, Lambert JC, Perret C, Cohen W, Oudot-Mellakh T, Antoni G, Alessi MC, Zelenika D, Cambien F, Tiret L, Bertrand M, Dupuy AM, Letenneur L, Lathrop M, Emmerich J, Amouyel P, Treqouet DA, Morange PE (2011) Genetics of venous thrombosis: insights from a new genome wide association study. PLoS ONE 6:e25581

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Martincic D, Kravtsov V, Gailani D (1999) Factor XI messenger RNA in human platelets. Blood 94:3397–3404

    PubMed  CAS  Google Scholar 

  9. Cheng Q, Kantz J, Poffenberger G, Powers AC, Gailani D (2008) Factor XI protein in human pancreas and kidney. Thromb Haemost 100:158–160

    PubMed Central  PubMed  CAS  Google Scholar 

  10. Poli D, Zanazzi M, Antonucci E, Marcucci R, Rosati A, Bertoni E, Salvadori M, Liotta AA, Abbate R, Prisco D, Gensini GF (2005) High rate of recurrence in renal transplant recipients after a first episode of venous thromboembolism. Transplantation 80:789–793

    Article  PubMed  Google Scholar 

  11. Wattanakit K, Cushman M (2009) Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms. Curr Opin Pulm Med 15:408–412

    Article  PubMed Central  PubMed  Google Scholar 

  12. Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR (2008) Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol 19:135–140

    Article  PubMed Central  PubMed  Google Scholar 

  13. Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ (1994) Thrombosis and hemostasis in renal disease. Kidney Int 46:287–296

    Article  PubMed  CAS  Google Scholar 

  14. He R, Chen D, He S (2012) Factor XI: hemostasis, thrombosis, and antithrombosis. Thromb Res 129:541–550

    Article  PubMed  CAS  Google Scholar 

  15. Di Cera E (2007) Thrombin as procoagulant and anticoagulant. J Thromb Haemost 5:196–202

    Article  PubMed  Google Scholar 

  16. Rugeri L, Quelin F, Chatard B, De Mazancourt P, Negrier C, Dargaud Y (2010) Thrombin generation in patients with factor XI deficiency and clinical bleeding risk. Haemophilia 16:771–777

    Article  PubMed  CAS  Google Scholar 

  17. Tsai HM (2006) ADAMTS13 and microvascular thrombosis. Expert Rev Cardiovasc Ther 4:813–825

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  18. Anderson PJ, Gailani D, Feys HB, Gao W, Majerus EM, Vanhoorelbeke K, Sadler JE (2007) Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasma. Haematologica 92:1419–1422

    Article  PubMed  CAS  Google Scholar 

  19. Mikhailidis DP, Fonseca VA, Barradas MA, Jeremy JY, Dandona P (1987) Platelet activation following intravenous injection of a conventional heparin: absence of effect with a low molecular weight heparinoid (Org 10172). Br J Clin Pharmacol 24:415–424

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  20. Meltzer ME, Lisman T, de Groot PG, Meijers JC, Ie Cessie S, Doggen CJ, Rosendaal FR (2010) Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood 116:113–121

    Article  PubMed  CAS  Google Scholar 

  21. Hrafnkelsdottir T, Ottosson P, Gudnason T, Samuelsson O, Jern S (2004) Impaired endothelial release of tissue-type plasmogen activator in patients with chronic kidney disease and hypertension. Hypertension 44:300–304

    Article  PubMed  CAS  Google Scholar 

  22. Brodsky JB, Burgess GE III (1975) Pulmonary embolism with factor XI deficiency. JAMA 1156:234–237

    Google Scholar 

  23. Bolton-Maggs PH, Peretz H, Butler R, Mountford R, Keeney S, Zacharski L, Zivelin A, Seligsohn U (2004) A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost 2:1–7

    Article  Google Scholar 

  24. von dem Borne PA, Bajzar L, Meijers JC, Nesheim ME, Bouma BN (1997) Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest 99:2323–2327

    Article  Google Scholar 

  25. Tuszynski G, Bevacqua S, Schmaier A, Colman R, Walsh P (1982) Factor XI antigen and activity in human platelets. Blood 59:1148–1156

    PubMed  CAS  Google Scholar 

  26. Pedicord DL, Seiffert D, Blat Y (2007) Feedback activation of factor XI by thrombin does not occur in plasma. Proc Natl Acad Sci USA 104:12860–12885

    Article  CAS  Google Scholar 

  27. Bicer M, Yanar M, Tuydes O (2009) Spontaneous deep vein thrombosis in hemophilia A: a case reports. Cases J 2:6390

    Article  PubMed Central  PubMed  Google Scholar 

  28. Pruthi RK, Heit JA, Green MM, Emiliusen LM, Nichols WL, Wilke JL, Gastineau DA (2000) Venous thromboembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden). Haemophilia 6:631–634

    Article  PubMed  CAS  Google Scholar 

  29. Casserly LF, Reddy SM, Dember LM (2000) Venous thromboembolism in end-stage renal disease. Am J Kidney Dis 36:405–411

    Article  PubMed  CAS  Google Scholar 

  30. Kamphuisen PW, Rosendaal FR, Eikenboom JC, Bos R, Bertina RM (2000) Factor V antigen levels and venous thrombosis: risk profile, interaction with factor V leiden, and relation with factor VIII antigen levels. Arterioscler Thromb Vasc Biol 20:1382–1386

    Article  PubMed  CAS  Google Scholar 

  31. Boehlen F, Hohlfeld P, Extermann P et al (2000) Platelet count at term pregnancy: a reappraisal of the threshold. Obvstet Gynecol 95:29–33

    Article  CAS  Google Scholar 

  32. Hellgren M, Blomback M (1981) Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 12:141–154

    Article  PubMed  CAS  Google Scholar 

  33. Salvagno GL, Lippi G, Franchini M, Targher G, Montagnana M, Franchi M, Guidi GC (2007) The cost-benefit ratio of screening pregnant women for thrombophilia. Blood Transfus 5:189–203

    PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (Grant No. 2012002096).

Author information

Authors and Affiliations

  1. School of Systems Biomedical Science, Soongsil University, 511 Sangdo-dong, Dongjak-gu, Seoul, 156-743, Korea

    Minyoung Kong, Younyoung Kim & Chaeyoung Lee

Authors
  1. Minyoung Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Younyoung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chaeyoung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chaeyoung Lee.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 44 kb)

Supplementary material 2 (DOC 32 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kong, M., Kim, Y. & Lee, C. Functional investigation of a venous thromboembolism GWAS signal in a promoter region of coagulation factor XI gene. Mol Biol Rep 41, 2015–2019 (2014). https://doi.org/10.1007/s11033-014-3049-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3049-1

Keywords

Search

Navigation